ACSA-2, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-ACSA-2, Mouse antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ACSA-2, Mouse |
| Clone | REA969 |
| Host Species | Recombinant Human |
| Reactive Species | mouse |
| Isotype | IgG1 |
| Format | APC-Vio 770 conjugate |
| Size | 30 µg in 200 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | ACSA-2 Antibody, anti-mouse, APC-Vio® 770, REAfinity™. Clone REA969 recognizes the mouse ACSA-2 antigen (ACSA-2: astrocyte cell surface antigen-2), which has been developed for the detection of astrocytes from cell suspensions of mouse neural tissue based on the expression of the ACSA-2 protein. The ACSA-2 antigen is specifically expressed on GLAST (ACSA-1) positive astrocytes and is therefore a specific marker of astrocytes in the developing and neonatal mouse central nervous system (CNS). The percentage of ACSA-2 positive astrocytes differs according to the mouse age and the brain region. | Additional information: Clone REA969 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | ACSA2 |
| Gene, Accession # | Gene ID: 11932 |
| Catalog # | 130-116-247 |
| Price | $160 |
| Order / More Info | ACSA-2, Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Sharma, K. et al. (2015) Cell type- and brain region-resolved mouse brain proteome. Nat. Neurosci. 18 (12): 1819-1831. | Holt, L. M. and Olsen, M. L. (2016) Novel applications of magnetic cell sorting to analyze cell-type specific gene and protein expression in the central nervous system. PLoS One 11 (2): e0150290. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies